期刊文献+

人舌鳞癌Tca8113细胞荷瘤裸鼠体内诱导耐药性的实验研究 被引量:2

The study of inducing mutidrug resistance in nude mice bearing tumors of human tongue squamous cell carcinoma Tca8113 cell
原文传递
导出
摘要 目的:探讨人舌鳞癌细胞荷瘤裸鼠体内化疗药物持续刺激状态下,肿瘤的生长及其耐药性的变化情况。方法:采用BALB/c-nu/nu裸鼠皮下接种Tca8113细胞悬液,待裸鼠成瘤后,采用卡铂(Carboplatin,CBP)进行小剂量长期暴露法诱导肿瘤耐药,以观察体内肿瘤耐药性的产生、肿瘤的生长变化及其各种耐药蛋白的表达。用免疫组化法检测部分耐药蛋白表达情况,RT-PCR检测相关耐药基因表达情况。结果:诱导后Tca8113/卡铂在免疫组化和RT-PCR检测中,MRP、GST-π等表达升高,TopoⅡ表达降低。结论:利用荷瘤裸鼠体内给药诱导肿瘤耐药性的产生可以更好地模拟临床舌鳞癌MDR的发生发展过程及其生物学特性,为多药耐药性及其逆转的进一步研究提供了一个有价值的研究平台。 Objective:To study the muhidrug resistance phenotype in nude mice bearing tumors of Tca8113 cell by espousing to Carboplatin.Method:The Tca8113 cells were injected subcutaneously in both sides of armpit of nude mice with the concentration of 5×10^6/0.1 ml.Two weeks after injection Carboplatin was used subcutaneously around the tumor 10 mg/g(weight)each day in Tca8113/CBP group while Tca8113 group was injected with physiologic saline.Mice were sacrificed about 13 weeks after drug inducing.The tumors were examined by Immunocytochemistry,RT-PCR et,al.Result:After espousing to Carboplatin,MDR of Tca8113/CBP group was associated with over expression of MDR,MRP,GST-πboth in protein and gene levels than Tca8113 group.Conclusion:The study showed MDR phenotype was elevated obviously in the inducing group,and in vivo inducing MDR was a good way to establish investigation platform for MDR mechanisms and reversing study.
作者 冯戈 王大章 陈槐卿 何嘉 冷卫东 FENG Ge;WANG Da-zhang;CHEN Huai-qing;HE Jia;LENG Wei-dong(Key Laboratory of Oral Biomedical Engineering Ministry of Education,Sichuan University,Chengdu 610041,China)
出处 《临床口腔医学杂志》 2007年第2期78-81,共4页 Journal of Clinical Stomatology
基金 国家自然科学基金资助项目(39970798) 四川大学优秀博士论文研究基金资助项目(0040305505010)
关键词 TEA8113细胞 多药耐药性 卡铂 裸鼠 Tca8113 cell line muhidrug resistance carboplatin(CBP) nude mice
  • 相关文献

参考文献8

  • 1Ramachandran C,Wellham LL.Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts[J].Anticancer Res,2003,23 (3B):2681-90.
  • 2Shionoya M,Jimbo T,Kitagawa M,et al.Tohgo A.DJ-927,a novel oral taxane,overcomes P-glycoprotein-mediated multidrug resistance in vitro and in vivo[J].Cancer Sci,2003,94(5):459-466.
  • 3Blanc E,Goldschneider D,Ferrandis E,et al.MYCN enhances P-gp/MDR1 gene expression in the human metastatic neuroblastoma IGR-N-91 model[J].Am J Pathol,2003,163 (1):321-331.
  • 4Warmann SW,Heitmann H,Teichmann B,et al.Effects of P-glycoprotein modulation on the chemotherapy of xenotransplanted human hepatoblastoma[J].Pediatric Hematology &Oncology,2005,22 (5):373-386.
  • 5Dupuy M,Blache Y,Bailly C,et al.In vitro and in vivo pharmacological characterisation of the antitumourpropertiesof pyrido[1',2':1,2] imidazo[4,5-h] quinazoline[J].Anticancer Res,2002,22(6A):3365-71.
  • 6Warmann S,Hunger M,Teichmann B,et al.The role of the MDRI gene in the development of multidrug resistance in human hepatoblastoma:clinical course and in vivo model[J].Cancer,2002,95 (8):1795-801.
  • 7Ihnat MA,Nervi AM,Anthony SP,et al.Effects of mitomycin C and carboplatin pretreatment on multidrug resistance-associated Pglycoprotein expression and on subsequent suppression of tumor growth by doxorubicin and paclitaxel in human metastatic breast cancer xenografted nude mice[J].Oncol Res,1999,11 (7):303-310.
  • 8张萍,王大章,郑光勇,廖楚航.体外短期化疗诱导Tca8113细胞株产生耐药性的研究[J].华西口腔医学杂志,2003,21(1):70-73. 被引量:7

二级参考文献4

  • 1[1]Izquierdo MA, Scheffer GL, Flens MJ, et al. Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors. Am J Pathol, 1996, 148(3): 877-887
  • 2[2]Chaudhary PM, Roninson IB. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J Natl Cancer Inst, 1993, 85(8):632-639
  • 3[3]Hu XF, Slater A, Wall DM, et al. Rapid up-regulation of mdr1 expression by anthracyclines in a classical multidrug-resistant cell line. Br J Cancer, 1995, 71(5): 931-936
  • 4[4]Abbaszadegan MR, Futscher BW, Klimecki WT, et al. Analysis of multidrug resistance-associated protein (MRP) messenger RNA in normal and malignant hematopoietic cells. Cancer Res, 1994, 54(17): 4676-4679

共引文献6

同被引文献18

  • 1陈公琰,杨朝阳,洪璇,王萌,路璐,张长海.人肺腺癌耐药细胞模型的建立及生物学特性的初步鉴定[J].中华医学杂志,2007,87(13):924-926. 被引量:7
  • 2冯戈,王大章,陈槐卿,何嘉,冷卫东.体外诱导Tca8113细胞产生耐药性的分析[J].华西口腔医学杂志,2007,25(2):184-187. 被引量:6
  • 3Bmheim S, Bruland OS, Breistol K, et al. Human osteosarcoma xenografts and their sensitivity to chemotherapy. Pathol Oncol Res, 2004,10(3) :133-141.
  • 4Chang CC, Liang YC, Klutz A, et al. Reversal of multidrug resist-ance by two nordihydroguaiaretic acid derivatives, M4N and maltose- M3N, and their use in combination with doxorubicin or paclitaxel. Cancer Chemother Pharmacol, 2006,58 (5) :640-653.
  • 5Engel JB, Sehally AV, Halmos G, et al. Targeted therapy with a eytotoxic somatostatin analog, AN-238, inhibits growth of human experimental endometrial carcinomas expressing muhidrug resistance protein MDR-1. Cancer, 2005,104(6) :1312-1321.
  • 6Engel JB, Schally AV, Halmos G, et al. Experimental therapy of human endometrial cancers with a targeted cytotoxic bombesin analog AN-215 : low induction of muhidrug resistance proteins. Eur J Cancer, 2005,41 (12) : 1824-1830.
  • 7Miraeeo C, Maellaro E, Paeenti L, et al. Evaluation of MDRI, LRP, MRP, and topoisomerase Ⅱ alpha gene mRNA transcripts before and after interferon-alpha, and correlation with the mRNA expression level of the telomerase subunits hTERT and TEP1 in five unselected human melanoma cell lines. Int J Oncol, 2003,23 ( 1 ) :213- 220.
  • 8Wang B, Ngoi S, Wang J, et al. The promoter region of the MDR1 gene is largely invariant, but different single nucleotide polymorphism haplotypes affect MDR1 promoter activity differently in different cell lines. Mol Pharmacol, 2006,70( 1 ) :267-276.
  • 9Weerasinghe P, Hallock S, Tang SC, et al. Sanguinarine overcomes P-glycoprotein-mediated multidrug-resistance via induction of apoptosis and oncosis in CEM-VLB 1000 cells. Exp Toxicol Pathol, 2006,58( 1 ) :21-30.
  • 10Watson MB,Lind MJ,Cawkwell L.Establishment of in vitro models of chemotherapy resistance[J].Anticancer Drugs,2007,18(7):749-754.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部